| Document |
Document Title |
|
JPH02504153A |
The present invention relates to new L-Fucose analogs, their method of preparation, the application of such analogs to the preparation of new glycals, anthracyclines obtained by using such glycals and utilization of such anthracyclines a...
|
|
JPH02503685A |
Novel Cyclopolyglycuronic acid compounds which are useful in the treatment of symptom relief in human disease including acne, blackheads and other facial lesions.
|
|
JPH02229199A |
NEW MATERIAL: A chemically and sterically pure synthetic amphipathic glycoconjugate represented by formula I [wherein the saccharide ring is a monosaccharide such as glucose or galactose; X is O or NH; R is a choline derivative group or ...
|
|
JPH02223576A |
NEW MATERIAL:A triflate expressed by the formula (R and R' are cyclic or acyclic alkyl; n is 1 or 2). USE: Capable of readily synthesizing various optically active substances or cyclic ether compounds and extremely useful for producing t...
|
|
JPH02121947A |
PURPOSE: To obtain a 2-ketopolyhydroxy-6C-carboxylic acid, useful for producing vitamin C, simply and profitably without producing a by-product salt by subjecting a waste fermentation liq. after the removal of a biomass and calcium ions ...
|
|
JPH0285287A |
NEW MATERIAL:A compound of formula I (R1 and R2 are H or the protecting group for the amino group; R3-R5 are H or the protecting group for OH) and a salt thereof. EXAMPLE: 5-[(2R),(3R)-4-Benzyloxy-2,3-isopropylidenedioxy-trans-butyl
iden...
|
|
JPH02500745A |
The invention relates to a process for the treatment of tumors in animals with water soluble square-planar cis platinum(II) four-coordinate complexes comprising different nonovalent and divalent organic cations. Monovalent cations includ...
|
|
JPH0269492A |
PURPOSE: To produce the subject compound on an industrial scale at a low cost by hydrolyzing chalaza and vitelline membrane of chicken's egg with an acid and separating and purifying the separated sialic acid with an adsorbent. CONSTITUT...
|
|
JPH0262887A |
NEW MATERIAL: 5-C-Hydroxymethyl hexose compound in which the hexose group is selected from D- or L-isomers of galactose, glucose, mannose, fructose, sorbose, and tagatose, and the galactose group is galactropyranose and galactofuranose, ...
|
|
JPH0245496A |
NEW MATERIAL: A compound represented by formula I (X, Y are an optionally sulfated uronic acid residue, residue of non-uronic acid spacer having substituent such as negatively charged carboxylate group, etc., etc.; R is H, a 1-20C alkyl;...
|
|
JPH024785A |
NEW MATERIAL: A compd. represented by the formula (wherein R1 is H or oxo, R2 is methyl or l-hydroxyethyl, R3 is H, methyl or rhamnosyloxycarbonyl, R4 is H, 2-hydroxypropyl, acetoxy or methyl and bonds between C1 and C2 and between C3 an...
|
|
JPH01299294A |
NEW MATERIAL:A compound expressed by formula I [M is alkaline (earth) metal or ammonium]. EXAMPLE: Potassium 5-acetamido-4,8-anhydro-3,5-dideoxy-D-glycero-D-galacto- nonulosonate USE: An antiviral, antinephritic and antidement agents. PR...
|
|
JPH0154669B2 |
|
|
JPH0149354B2 |
|
|
JPH01233292A |
PURPOSE: To advantageously glycosylate hydroxyl groups of a sugar anomer in good yield of glycosides in a small number of reaction steps, by reacting the above-mentioned hydroxyl groups with a specific thiocarbonate to directly thioglyco...
|
|
JPH01226896A |
PURPOSE: To obtain an oxidized substd. saccharide suitable for use as a detergent or cleaner in combination with a surfactant in a high yield by oxidizing a specified saccharide with oxygen (-contg. gas) in an aq. mixture in the presence...
|
|
JPH01226895A |
NEW MATERIAL:O-α-D-Glucuronosyl-(1→2)-O-β-D-xylosyl-(1→4)-
[O-β-D-xylos yl-1→4)]n- D-xylose expressed by the formula (n is 1 or 2). USE: An antitumor agent and immunopotentiator. PREPARATION: A xylan-containing natural product (...
|
|
JPH0138797B2 |
Novel X-ray contrast agents, i.e., N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gul
onamido)is ophthalamide, and intermediates.
|
|
JPH0134997B2 |
This invention is directed to a derivative of a reducing sugar, said reducing sugar having molecular weights of from 120 to 2000, in that said derivative having at least one methylol group which branches the carbon structure of the reduc...
|
|
JPH01151593A |
Known substituted hydroxypiperidines are used as antiviral agents in human and veterinary medicine.
|
|
JPH01131156A |
NEW MATERIAL: N-benzoyl-3,4,5-tri-o-benzyl-3,4,5-trihydroxy-piperidine-2-a
ldehyde of formula I, N-benzoxyl-2-hydroxymethyl-3,4,5-tri-O-benzl-3,4,5- trihydroxypiperidine of formula II, and N, 7-O-cyclocarbonato-2- hydroxymethyl-3,4,5-tri...
|
|
JPH01104089A |
NEW MATERIAL: Compds. of the formula (where R1 is H, a 1-4C alkyl or an alkali metal; R2 is a single bond or a divalent group of monosaccharides; and glc is glucose). EXAMPLE: Δ4,5-glucuronic acid-glucose-rhamnose-glucose. USE: Starting...
|
|
JPS6468388A |
PURPOSE: To efficiently obtain the titled compound under mild condition and through short production steps, by treating an aromatic O-glycoside compound in the presence of a Lewis acid catalyst. CONSTITUTION: For example, a sugar or deox...
|
|
JPS648638B2 |
|
|
JPS646191B2 |
The invention relates to alpha -hydroxyalkyl-3,4,5-trihydroxypiperidines defined by Formula (I), infra, and pharmaceutical compositions and medicaments containing said compounds. Also included in the invention are methods for the use of ...
|
|
JPS6346153B2 |
PURPOSE:To manufacture efficiently sugar carboxylic acid or sugar lactone in a high yield by electrolytically oxidizing an electrolytic soln. contg. an Ru compound and a saccharide to synthesize sugar carboxylic acid, regenerating the re...
|
|
JPS6312874B2 |
|
|
JPS6312877B2 |
|
|
JPS6312078B2 |
|
|
JPS6312074B2 |
|
|
JPS62294619A |
PURPOSE: An antitrichophytial agent useful for treating skin diseases such as athlete's foot, etc., free from side effects, containing antibiotic substance SI-4228, antibiotic substance SI-4228B, etc., produced by a bacterium belonging t...
|
|
JPS6256153B2 |
|
|
JPS62234091A |
Efomycin G, its preparation, and its use as a growth promoter in animals.
|
|
JPS62228092A |
NEW MATERIAL:2,3-O-acetal or ketal of 2-keto-D-glucaric acid or its salt. USE: A synthetic intermediate for D-glucosaccharoascorbic acid having antioxidation activity. PREPARATION: 2-Keto-D-glucaric acid is subjected to acetalization or ...
|
|
JPS62201894A |
NEW MATERIAL:A compound expressed by formula I [R is formula II or; -A- is -CO- or -CH(OH)-]. EXAMPLE: Myricanol-5-O-6'-galloyl-β-D-glucopyranoside expressed by formula III. USE: A prostaglandin I2 formation accelerator useful as a reme...
|
|
JPS62178597A |
PURPOSE: To readily and efficiently separate the titled compound and obtain each of the α-anomer and β-anomer in high purity and yield, by carrying out fractionation and crystallization using a mixed solvent of an alcohol consisting of...
|
|
JPS62145015A |
PURPOSE: To provide an anti-inflammatory agent containing sialic acid as an active component. CONSTITUTION: The objective anti-inflammatory agent contains sialic acid, especially N-acetylneuraminic acid as an active component. Sialic aci...
|
|
JPS6263598A |
PURPOSE: To readily obtain the titled water-soluble and odorless compound useful as a reducing agent for the first permanent waving solution, etc., by reacting a sugar lactone compound with an aminoalkanethiol. CONSTITUTION: (A) A sugar ...
|
|
JPS6236394A |
Novel esterified oligosaccharides including at least one esterified disaccharide unit consisting of a uronic acid residue and a hexosamine residue can be topically applied to mammalian skin to improve the appearance of hair and other ben...
|
|
JPS62919B2 |
1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuranurono-6,3-lactone has the formula Said substance has a marked antiblastic action. The substance is less toxic compared with the known preparation of similar action.
|
|
JPS61257190A |
PURPOSE: To obtain the titled compound useful as a production raw material for the remedy of bacteriosis, etc., economically on an industrial scale in a mass, by treating a 2-ketoglutaric acid dehydrogenase to a mixture of 2- ketoglutari...
|
|
JPS61233695A |
The use of microbiologically produced compounds and their mixtures, called efomycins, for increasing the productiveness in productive livestock, and their preparation, furthermore novel efomycins, and their mixtures as novel chemical com...
|
|
JPS61210081A |
The present invention relates to novel labdanes, intermediates and processes for the preparation thereof. The compounds have the ability to reduce elevated intraocular pressure and can, therefore, be used as medicaments.
|
|
JPS61194037A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS61194099A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6126526B2 |
Glucuronic acid or a salt of this acid is reacted, in a solvent, with a substituted phenylaminoalcohol of formula I, in which R1 represents an alkyl with 1 to 4 C atoms, R2 an alkyl with 1 or 2 C atoms and R3 an alkyl with 4 to 16 C atom...
|
|
JPS6121561B2 |
A process for the separation and/or purification of oligo- and polyhydroxy compounds by introducing and subsequently eliminating protective groups, wherein oligo- and polyhydroxy compounds are reacted with bis(ethyl-pivaloyloxy)-diboroxa...
|
|
JPS6116373B2 |
A process for the separation and/or purification of oligo- and polyhydroxy compounds by introducing and subsequently eliminating protective groups, wherein oligo- and polyhydroxy compounds are reacted with bis(ethyl-pivaloyloxy)-diboroxa...
|
|
JPS6111249B2 |
1. Process for the production of polyether polyols having an average molecular weight in the range of 200 to 10,000 and an average hydroxyl functionality of 2.0 to 7.0 by the addition of one or more cyclic ethers, in the presence of an a...
|
|
JPS6163691A |
New functional ganglioside derivatives comprising ester, amide and peracylated derivatives of gangliosides, preparation procedures therefor, pharmaceutical preparations containing the same, and the therapeutic use of the derivatives.
|
